{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:22:24Z","timestamp":1781198544931,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Using the FDA adverse event reporting system (FAERS) database to analyze the safety profile of Dexmedetomidine and provide guidance for clinical application.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from the FAERS database from the first quarter of 2004 to the third quarter of 2023 were collected. Reporting odds ratio (ROR), the proportional reporting ratio (PRR), and the Bayesian confidence propagation neural network (BCPNN) were employed to detect and assess adverse events associated with Dexmedetomidine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1910 reports of Dexmedetomidine as the primary suspect drug were obtained. After screening, 892 preferred terms were obtained, including 52 new preferred terms not mentioned in the drug insert. The common adverse events of Dexmedetomidine include bradycardia, cardiac arrest, hypotension, diabetes insipidus, arteriospasm coronary and agitation. Notably, cardiac disorders exhibited the highest number of reports and the highest signal intensity in the system organ class. Among the new preferred terms, those with high signal intensity include transcranial electrical motor evoked potential monitoring abnormal, acute motor axonal neuropathy, trigemino-cardiac reflex, glossoptosis, floppy iris syndrome, phaeochromocytoma crisis, postresuscitation encephalopathy and diabetes insipidus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study mined and evaluated adverse events associated with Dexmedetomidine and also identified new adverse events. This could help alert clinicians to new adverse events not mentioned in the drug inserts, reducing the risk of drug.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1419196","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:47:26Z","timestamp":1724406446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database"],"prefix":"10.3389","volume":"15","author":[{"given":"Yichun","family":"Shuai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0034-7094(12)70110-1","article-title":"Dexmedetomidine: current role in anesthesia and intensive care","volume":"62","author":"Afonso","year":"2012","journal-title":"Braz. J. Anesthesiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neucli.2017.11.001","article-title":"Clonidine administration during intraoperative monitoring for pediatric scoliosis surgery: effects on central and peripheral motor responses","volume":"48","author":"Calder\u00f3n","year":"2018","journal-title":"Neurophysiol. Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1517\/17425255.4.5.619","article-title":"Dexmedetomidine: sedation, analgesia and beyond","volume":"4","author":"Chrysostomou","year":"2008","journal-title":"Expert Opin. Drug Metabolism and Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1503\/cmaj.071112","article-title":"Sex-and age-based differences in the delivery and outcomes of critical care","volume":"177","author":"Fowler","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jcrc.2009.05.015","article-title":"A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients","volume":"24","author":"Gerlach","year":"2009","journal-title":"J. Crit. Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/anae.14657","article-title":"Intra\u2010operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta\u2010analysis with trial sequential analysis","volume":"74","author":"Grape","year":"2019","journal-title":"Anaesthesia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bja.2022.06.020","article-title":"Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials","volume":"129","author":"Heybati","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/00000542-200411000-00005","article-title":"Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers","volume":"101","author":"Hsu","year":"2004","journal-title":"Anesthesiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tjog.2022.11.010","article-title":"Efficacy and safety of intravenous dexmedetomidine as an adjuvant to general anesthesia in gynecological surgeries: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Hung","year":"2023","journal-title":"Taiwan. J. Obstetrics Gynecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1161\/CIRCULATIONAHA.112.000936","article-title":"Perioperative dexmedetomidine improves outcomes of cardiac surgery","volume":"127","author":"Ji","year":"2013","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/PCC.0000000000003376","article-title":"Dexmedetomidine withdrawal syndrome in children in the PICU: systematic review and meta-analysis","volume":"25","author":"Knapp","year":"2024","journal-title":"Pediatr. Crit. Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4097\/kjae.2015.68.6.575","article-title":"Effective dose of dexmedetomidine to induce adequate sedation in elderly patients under spinal anesthesia","volume":"68","author":"Ko","year":"2015","journal-title":"Korean J. Anesthesiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/0960327112454896","article-title":"Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature","volume":"32","author":"Kukoyi","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/0971-9784.185517","article-title":"Effect of dexmedetomidine on diseased coronary vessel diameter and myocardial protection in percutaneous coronary interventional patients","volume":"19","author":"Kundra","year":"2016","journal-title":"Ann. Card. Anaesth."},{"key":"B16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00134-022-06712-2","article-title":"Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lewis","year":"2022","journal-title":"Intensive Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12871-016-0217-y","article-title":"Effects of Dexmedetomidine on motor- and somatosensory-evoked potentials in patients with thoracic spinal cord tumor: a randomized controlled trial","volume":"16","author":"Li","year":"2015","journal-title":"BMC Anesthesiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/ALN.0b013e3181d74f55","article-title":"Susceptibility of transcranial electric motor-evoked potentials to varying targeted blood levels of dexmedetomidine during spine surgery","volume":"112","author":"Mahmoud","year":"2010","journal-title":"Anesthesiology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/EJA.0b013e32833e266d","article-title":"Dexmedetomidine: new insights","volume":"28","author":"Mantz","year":"2011","journal-title":"Eur. J. Anaesthesiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/CCM.0000000000005469","article-title":"Sex differences in treatment of adult intensive care patients: a systematic review and meta-analysis","volume":"50","author":"Modra","year":"2022","journal-title":"Crit. Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2344\/anpr-69-01-02","article-title":"Coronary spasm during postoperative sedation with dexmedetomidine","volume":"69","author":"Sato","year":"2022","journal-title":"Anesth. Prog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1213\/ANE.0000000000005344","article-title":"Perioperative diabetes insipidus caused by anesthetic medications: a review of the literature","volume":"134","author":"Van Decar","year":"2022","journal-title":"Anesth. and Analgesia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00134-002-1579-9","article-title":"A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit","volume":"29","author":"Venn","year":"2003","journal-title":"Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/andr.13533","article-title":"A real-world pharmacovigilance study of FDA adverse event reporting system events for sildenafil","volume":"12","author":"Wang","year":"2023","journal-title":"Andrology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/bja\/ael379","article-title":"Clonidine reduces the excitability of spinal dorsal horn neurones","volume":"98","author":"Wolff","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1177\/1098612X221077023","article-title":"Ophthalmic effects of dexmedetomidine, methadone and dexmedetomidine\u2013methadone in healthy cats and their reversal with atipamezole","volume":"24","author":"Wolfran","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12885-023-11201-w","article-title":"A real-world disproportionality analysis of rucaparib: post-marketing pharmacovigilance data","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1320458","DOI":"10.3389\/fphar.2023.1320458","article-title":"A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1419196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:47:38Z","timestamp":1724406458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1419196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":30,"alternative-id":["10.3389\/fphar.2024.1419196"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1419196","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"article-number":"1419196"}}